US Stock MarketDetailed Quotes

ZTS Zoetis

Watchlist
  • 157.520
  • -7.410-4.49%
Close Feb 14 16:00 ET
  • 157.840
  • +0.320+0.20%
Pre 09:17 ET
70.54BMarket Cap28.80P/E (TTM)

About Zoetis Company

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Company Profile

SymbolZTS
Company NameZoetis
Listing DateFeb 1, 2013
Issue Price26.00
Founded1952
CEOMs. Kristin C. Peck
MarketNYSE
Employees13800
Fiscal Year Ends12-31
Address10 Sylvan Way
CityParsippany
ProvinceNew Jersey
CountryUnited States of America
Zip Code07054
Phone1-973-822-7000
Websitehttp://www.zoetis.com

Company Executives

  • Name
  • Position
  • Salary
  • Kristin C. Peck
  • Director and Chief Executive Officer
  • 15.24M
  • Jeannette Ferran Astorga
  • Executive Vice President, Corporate Affairs, Communications and Chief Sustainability Officer
  • --
  • Wetteny Joseph
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 4.25M
  • Julie Fuller
  • Executive Vice President, Global Operations and Chief Human Resources Officer
  • --
  • Roxanne Lagano
  • Chief Human Resources Officer, Executive Vice President, Global Operations and Interim General Counsel and Corporate Secretary
  • --
  • Keith Sarbaugh
  • Executive Vice President, Chief Digital Officer and Chief Technology Officer
  • --
  • Jamie Brannan
  • Executive Vice President and Chief Commercial Officer
  • --
  • Nick Ashton
  • Executive Vice President and President, Global Manufacturing and Supply
  • --
  • Dr. Robert J. Polzer, PhD
  • Executive Vice President and President, Research and Development
  • 2.44M
  • Rimma Driscoll
  • Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
  • --
  • Michael B. McCallister
  • Non-Executive Chairman of the Board
  • 490.00K
  • Jared Shriver
  • President, U.S. Operations
  • --
  • Gavin D.K. Hattersley
  • Director
  • --
  • Frank A. D'Amelio
  • Independent Director
  • 340.50K
  • Paul M. Bisaro
  • Independent Director
  • 340.00K
  • Robert W. Scully
  • Independent Director
  • 365.00K
  • Dr. Willie M. Reed
  • Independent Director
  • 370.00K
  • Antoinette R. Leatherberry
  • Independent Director
  • 340.00K
  • Vanessa Broadhurst
  • Independent Director
  • 341.00K
  • Gregory Norden
  • Independent Director
  • 365.00K
  • Louise M. Parent
  • Independent Director
  • 370.00K
  • Sanjay Khosla
  • Independent Director
  • 340.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025
Earnings Season Underway
Earnings season is here. What to know?